Olbetam is indicated as alternative or adjunct treatment to reduce triglyceride levels in patients who have not responded adequately to other treatments such as statin or fibrate treatment for
Olbetam is indicated as alternative or adjunct treatment to reduce triglyceride levels in patients who have not responded adequately to other treatments such as statin or fibrate treatment for
Before instituting OLBETAM therapy, attempts should be made to control serum lipids with Acipimox is structurally related to nicotinic acid. The risk of muscle toxicity is increased when nicotinic acid is administered concomitantly with a statin
Before instituting OLBETAM therapy, attempts should be made to control serum lipids with Acipimox is structurally related to nicotinic acid. The risk of muscle toxicity is increased when nicotinic acid is administered concomitantly with a statin